Digital Opportunities for Chemical Producers

February 13, 2018

Chemical producers were among the first to use digital technologies extensively. From the days of the earliest digital plant controllers, they have used data to improve their operations. Their R&D teams have tapped large data sets in their search for better molecules and processes. And for at least 40 years, engineers have used computer-aided design (CAD) systems to design their plants.

Spotlight

SAGE Therapeutics

SAGE Therapeutics is a neuroscience-focused company developing medicines to treat life-threatening, rare CNS disorders. Our mission is to make life better for patients with central nervous systems diseases by discovering, developing, and delivering important new medicines to the market. To achieve that mission we leverage compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers. SAGE’s lead program, SAGE-547, is in clinical development for super-refractory status epilepticus (SRSE) and is the first of many compounds the company is developing in its portfolio of potential seizure medicines.

OTHER WHITEPAPERS
news image

EH&S GUIDELINES FOR PEROXIDE FORMING CHEMICALS

whitePaper | August 11, 2022

This guide will help you manage your peroxide forming chemicals and outlines the procedures for the required stabilization of peroxide forming chemicals and destruction of peroxides prior to disposal.

Read More
news image

Empowering Operators and Frontline Process Engineers with AI-Powered Operational Analytics

whitePaper | April 12, 2021

Today’s industries face mounting challenges in assuring the best operational performance of assets, both mechanical and process. Managing asset performance is the key element of controlling the operational risk that varying situations can present.

Read More
news image

THE INTELLIGENT ENTERPRISE FOR THE OIL AND GAS INDUSTRY

whitePaper | April 30, 2021

Learn SAP’s perspective on where the oil and gas industry will go and how SAP contributes to the evolution of the industry in a digital world. SAP Industries White Paper | Oil and Gas© 2021 SAP SE or an SAP affiliate company. All rights reserved. 2“In the experience economy, oil and gas companies that are intelligent enterprises embrace market standards and the cloud to innovate and differentiate.”

Read More
news image

THE INTELLIGENT ENTERPRISE FOR THE CHEMICAL INDUSTRY

whitePaper | January 14, 2023

As industries reexamine their partners and processes in a critical search for efficiency, chemical businesses are feeling increasing cost and margin pressure. Still, the companies that can adapt new models and automate their processes have an unprecedented opportunity to have an outsized positive impact.

Read More
news image

Halides Chemicals Pvt. Ltd. - Combining Quality And Reliability In Every Formula

whitePaper | December 22, 2022

Halides Chemicals Pvt. Ltd. was incorporated in the year 1995. The company was formed with a view in mind to provide quality Halo Succinimides for pharmaceutical as well as chemical industry.

Read More
news image

Employee Scheduling for Manufacturing: A Best Practices Guide

whitePaper | June 16, 2021

As demand continues to surge for many chemical manufacturers, ensuring adequate staffing to meet daily volume targets is a top-of-mind issue for plant managers. Read the guide to discover the best practices of employee scheduling you can leverage to improve the overall effectiveness of labor resources

Read More

Spotlight

SAGE Therapeutics

SAGE Therapeutics is a neuroscience-focused company developing medicines to treat life-threatening, rare CNS disorders. Our mission is to make life better for patients with central nervous systems diseases by discovering, developing, and delivering important new medicines to the market. To achieve that mission we leverage compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers. SAGE’s lead program, SAGE-547, is in clinical development for super-refractory status epilepticus (SRSE) and is the first of many compounds the company is developing in its portfolio of potential seizure medicines.

Events